FOLFIRINOX until progression, FOLFIRINOX with maintenance treatment, or sequential treatment with gemcitabine and FOLFIRI.3 for first-line treatment of metastatic pancreatic cancer: A randomized phase II trial (PRODIGE 35-PANOPTIMOX)
ANNÉE
2018
AUTEURS
Dahan L, Phelip JM, Le Malicot K, Williet N, Desrame J, Volet J, Petorin C, Malka D, Rebischung C, Aparicio T, Lécaille C, Rinaldi Y, Turpin A, Bignon A, Bachet JB, Seitz JF, Lepage C, Francois E
CONGRÈS/REVUE
ASCO
ÉTUDE
Localisation
LIEN PUBLICATIONS ASSOCIÉES